Found 34 matching trials
A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED) PHASE3 To determine the effect of ezetimibe and simvastatin given together, and ez...
Show More Location
Multiple Locations
Learn More & Join Trial
Sitosterolemia Extension Study (0653-004)(COMPLETED) PHASE3 This is an extension study for patients having unusually high absorption of...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025) PHASE3 The purpose of this study is to determine whether an investigational medica...
Show More Location
Multiple Locations
Learn More & Join Trial
Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018) PHASE3 The primary objective of this study is to evaluate the efficacy and the saf...
Show More Location
Multiple Locations
Learn More & Join Trial
An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED) PHASE3 The purpose of this study is to investigate additional cholesterol lowering...
Show More Location
Multiple Locations
Learn More & Join Trial
Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe (0653-070) PHASE3 To evaluate the LDL-C lowering in south african patients with primary hyper...
Show More Location
Multiple Locations
Learn More & Join Trial
Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED) PHASE3 The purpose of this study is to provide an investigational drug to patients...
Show More Location
Multiple Locations
Learn More & Join Trial
MD Ezetimibe Cyclosporine Interaction (0653-057) PHASE1 Study to determine the effect of multiple oral doses of ezetimibe on the ph...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042) PHASE3 Patients undergo 4-week placebo lead-in and diet period, and 12-week treatm...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial (Following a Meal) Lipoprotein Response in Participants With Primary Hypercholesterolemia (High Cholesterol) (MK-0653-072)(COMPLETED) PHASE3 A study to evaluate the cholesterol-lowering effects of ezetimibe in partic...
Show More Location
Multiple Locations
Learn More & Join Trial